We bring you the latest news from the healthcare about the health care in the United Kingdom. Do your have news for us? Contact the editor. Watch also this special movie.

woensdag 22 maart 2017

Nature Reviews Rheumatology - Table of Contents alert Volume 13 Issu 4

If you are unable to see the message below, click here to view.

Nature Reviews Rheumatology


Advertisement
Key Advances in Medicine eBook from Nature Reviews - FREE to download! 

This essential resource summarizes the groundbreaking clinical and biomedical discoveries of 2016 and highlights the trends to watch out for in 2017, making it a must read eBook for anyone with an interest in medical science. 

Download for free
 
TABLE OF CONTENTS
 
April 2017 Volume 13 Number 4
Nature Reviews Rheumatology cover
2015 2-year Impact Factor 10.531 Journal Metrics 2-year Median 7
In this issue
Research Highlights
News and Views
Reviews

Also this month
 Featured article:
What rheumatologists need to know about CRISPR/Cas9
Gary J. Gibson & Maozhou Yang


Subscribe
 
Facebook
 
RSS
 
Recommend to library
 
Twitter
 
Advertisement
Looking to recruit? Limited time offer from Naturejobs: 

Get a 20% discount on our Premium job posting package when you buy before March 31, 2017.

  • Reach a potential audience of 10.8 million users* via nature.com
  • Be seen first by candidates — your position will appear at the top of related searches for 60 days and be displayed prominently on the Naturejobs home page as Job of the Week.
  • Plus appear as 'Featured' in search results
Post a job now.

* Publisher data 2016
 
 
Advertisement
nature.com webcasts

Join us for our upcoming webcast followed by live Q&A:
NEW INNOVATIONS IN DRUG DELIVERY TECHNOLOGY

Presented by BioPharma Dealmakers

Date: Wednesday, March 29, 2017
Time: 8AM PDT | 11AM EDT | 4PM BST | 5PM CEST

REGISTER FOR FREE

Sponsored by: Corium International | Portal Instruments Inc. | TissueGen Inc. | TrioxNano
 
RESEARCH HIGHLIGHTS
Top

Rheumatoid arthritis: New player in RA pathogenesis brought to light
Published online: 16 February 2017
p195 | doi:10.1038/nrrheum.2017.19

PDF


Acute inflammatory arthritis: Potential therapies for chikungunya arthritis
Published online: 16 February 2017
p196 | doi:10.1038/nrrheum.2017.21

PDF


Inflammation: Hit the DEK!
Published online: 23 February 2017
p196 | doi:10.1038/nrrheum.2017.25

PDF


Experimental arthritis: Do you want to treat arthritis? IDO2!
Published online: 09 March 2017
p196 | doi:10.1038/nrrheum.2017.33

PDF


Spondyloarthropathies: E. coli links IBD to spondyloarthritis
Published online: 23 February 2017
p198 | doi:10.1038/nrrheum.2017.26

PDF


Systemic sclerosis: Antifibrotic effects of PDE4 blockade?
Published online: 09 March 2017
p198 | doi:10.1038/nrrheum.2017.34

PDF



IN BRIEF

Rheumatoid arthritis: The lung as a site for anti-CCP generation? | Vasculitis syndromes: Shared genetic risk for Behçet disease and Crohn's disease | Rheumatoid Arthritis: Sirukumab effective in patients refractory to anti-TNF therapy | Rheumatoid Arthritis: Baricitinib more effective than adalimumab
PDF

Nature Reviews Rheumatology
JOBS of the week
Associate Managing Editor - Infectious Diseases, Immunology and Rheumatology
EBSCO Health/Dynamed
Postdoctoral Fellow / Research Assistant
University of California - Davis
More Science jobs from
Nature Reviews Rheumatology
EVENT
International Conference on Osteoporosis, Arthritis and Musculoskeletal Disorders
21.09.17
Madrid, Spain
More science events from
 
NEWS AND VIEWS
Top
Spondyloarthropathies: Fine tuning the management of axial spondyloarthritis
Daniel Wendling & Clément Prati
Published online: 23 February 2017
p199 | doi:10.1038/nrrheum.2017.24
Updated recommendations for the management of axial spondyloarthritis provide a useful framework for physicians treating this disease. However, the guidance on use of biologic therapies and treat-to-target strategies seems to raise more questions than it answers.
Full Text | PDF

Gout: Risk of premature death in gout unchanged for years
Chang-Fu Kuo & Shue-Fen Luo
Published online: 02 March 2017
p200 | doi:10.1038/nrrheum.2017.27
The increased risk of mortality in patients with gout is increasingly recognized, and multiple guidelines call for better management of this disease and its comorbidities. A new study, however, has found that excess mortality in patients with gout has remained unchanged since 1999.
Full Text | PDF

Connective tissue diseases: Sjögren syndrome genetics vary according to ancestry
Tove Ragna Reksten & Roland Jonsson
Published online: 09 March 2017
p202 | doi:10.1038/nrrheum.2017.36
A pioneering new study scrutinising the genetic aetiology of Sjögren syndrome across different ancestries and clinical subtypes shows that the striking heterogeneity of associations observed in Sjögren syndrome cannot be explained by subphenotype differences alone.
Full Text | PDF | Supplementary information

 
REVIEWS
Top
What rheumatologists need to know about CRISPR/Cas9
Gary J. Gibson & Maozhou Yang
Published online: 09 February 2017
p205 | doi:10.1038/nrrheum.2017.6
This Review outlines what a rheumatologist needs to know about the development and advances in CRISPR/Cas9 genome editing technologies. The authors discuss the direct applications to rheumatic diseases, which are currently limited but are certain to increase rapidly in the near future.
Abstract | Full Text | PDF

Beyond TNF: TNF superfamily cytokines as targets for the treatment of rheumatic diseases
Michael Croft & Richard M. Siegel
Published online: 09 March 2017
p217 | doi:10.1038/nrrheum.2017.22
In this Review, the authors discuss the function of the TNF and TNF receptor superfamily, their role in rheumatic diseases such as rheumatoid arthritis and systemic lupus erythematosus, and how current knowledge is being translated into potential disease therapies.
Abstract | Full Text | PDF

The emerging safety profile of JAK inhibitors in rheumatic disease
Kevin L. Winthrop
Published online: 02 March 2017
p234 | doi:10.1038/nrrheum.2017.23
Janus kinase (JAK) inhibitors are emerging therapeutic agents for the treatment of rheumatic inflammatory diseases. In this Review, the author outlines the safety profile of JAK inhibitors, discussing the potential adverse effects associated with these drugs, such as malignancy, infections and reactivation of herpes zoster.
Abstract | Full Text | PDF

Haematopoietic stem cell transplantation for autoimmune diseases
Joost F. Swart, Eveline M. Delemarre, Femke van Wijk, Jaap-Jan Boelens, Jürgen Kuball, Jacob M. van Laar & Nico M. Wulffraat
Published online: 23 February 2017
p244 | doi:10.1038/nrrheum.2017.7
In this Review, the authors discuss the therapeutic application of haematopoietic stem cell transplantation in different autoimmune diseases, describing the immunological mechanisms and the risks and benefits of this procedure.
Abstract | Full Text | PDF

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events
Nature Reviews Rheumatology was previously published as Nature Clinical Practice Rheumatology.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/myaccount
(You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department

For print subscription enquiries, please contact our subscription department

For other enquiries, please contact our feedback department

Nature Publishing Group | One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2017 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group